ClinVar Miner

Submissions for variant NM_000372.5(TYR):c.229C>T (p.Arg77Trp)

gnomAD frequency: 0.00006  dbSNP: rs61753184
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000085933 SCV001770387 pathogenic not provided 2022-06-24 criteria provided, single submitter clinical testing In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 9259202, 10987646, 13680365, 23504663, 28451379, 31077556, 28976636, 19865097, 34426522, 32552135, 33124154)
Genome-Nilou Lab RCV000414815 SCV001821922 pathogenic Tyrosinase-negative oculocutaneous albinism 2021-07-22 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000085933 SCV002221234 pathogenic not provided 2024-10-26 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 77 of the TYR protein (p.Arg77Trp). This variant is present in population databases (rs61753184, gnomAD 0.008%). This missense change has been observed in individuals with oculocutaneous albinism (PMID: 9259202, 28976636, 31077556). ClinVar contains an entry for this variant (Variation ID: 99553). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 95%. This variant disrupts the p.Arg77 amino acid residue in TYR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21985232, 31077556). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
MGZ Medical Genetics Center RCV000414815 SCV002579975 pathogenic Tyrosinase-negative oculocutaneous albinism 2022-05-16 criteria provided, single submitter clinical testing
Baylor Genetics RCV003467006 SCV004207612 pathogenic SKIN/HAIR/EYE PIGMENTATION 3, LIGHT/DARK SKIN 2024-03-30 criteria provided, single submitter clinical testing
Retina International RCV000085933 SCV000118076 not provided not provided no assertion provided not provided
Baylor Genetics RCV000414815 SCV000328778 pathogenic Tyrosinase-negative oculocutaneous albinism 2015-05-15 no assertion criteria provided clinical testing This pathogenic variant has been previously described [PMID:9259202,23504663] and was found in trans with another pathogenic variant in TYR (NM_000372.4, c.229C>T) in an individual with autism, regression in language skills at 14mo of age, macrocephaly, joint laxity, atlantoaxial instability, fractures, delayed bone age, short stature, hip dysplasia, tyrosinase-negative oculocutaneous and cutaneous albinism and decrease pain sensitivity. A likely pathogenic de novo variant in TGFB2 (NM_003238.3, c.458G>A) was reported in the same individual. Heterozygotes for this variant are expected to be asymptomatic carriers.
PreventionGenetics, part of Exact Sciences RCV004739349 SCV005349760 pathogenic TYR-related disorder 2024-08-19 no assertion criteria provided clinical testing The TYR c.229C>T variant is predicted to result in the amino acid substitution p.Arg77Trp. This variant has been reported in the compound heterozygous state in individuals with oculocutaneous albinism (Spritz et al. 1997. PubMed ID: 9259202; Marti et al. 2017. PubMed ID: 28976636; Zhong et al. 2019. PubMed ID: 31077556). This variant is reported in 0.0080% of alleles in individuals of African descent in gnomAD. This variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/99553/). Given the evidence, we interpret this variant as pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.